Your browser doesn't support javascript.
loading
Economic evaluation of brentuximab vedotin for persistent Hodgkin lymphoma.
Babashov, V; Begen, M A; Mangel, J; Zaric, G S.
Afiliação
  • Babashov V; Telfer School of Management, University of Ottawa, Ottawa, ON.
  • Begen MA; Ivey Business School, Western University, London, ON;; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, and.
  • Mangel J; Department of Medicine, Division of Hematology, Schulich School of Medicine and Dentistry, Western University, London, ON.
  • Zaric GS; Ivey Business School, Western University, London, ON;; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, and.
Curr Oncol ; 24(1): e6-e14, 2017 Feb.
Article em En | MEDLINE | ID: mdl-28270727
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Curr Oncol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Curr Oncol Ano de publicação: 2017 Tipo de documento: Article